Boston Bio Systems Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Boston Bio Systems Ltd. on BSE

Load latest

Boston Bio Systems Ltd.

13 Aug 2024

8.59

1.30%

Corp. Note

Boston Bio Systems Ltd. - 531458 - Board Meeting Outcome for Board Meeting Outcome For Unaudited …

BSE India

Outcome of Board Meeting for unaudited financial results for the quarter ended June 30, 2024 as per regulation 30 and 33 of SEBI(Listing Obligation and Disclosure Requirements) Regulation, 2015 in line with prior intimation dated 6th August, 2024

pdf

Boston Bio Systems Ltd.

13 Aug 2024

8.59

1.30%

Result

Boston Bio Systems Ltd. - 531458 - Unaudited Financial Results For The Quarter Ended June 30, …

BSE India

Please find enclosed herewith financial results

pdf

Boston Bio Systems Ltd.

06 Aug 2024, 06:27PM

8.59

1.30%

Company Update

Boston Bio Systems Ltd. - 531458 - Intimation Of Board Meeting To Be Held On 13Th …

BSE India

Intimation of the Board Meeting to be held on 13th August, 2024 to approve standalone unaudited financial results of the company for june quarter, 2024

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Result

Boston Bio Systems Ltd. - 531458 - Results-Delay in Financial Results

BSE India

APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR THE 3RD QUATER ENDED ON 30TH DECEMBER, 2023.

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Corp. Note

Boston Bio Systems Ltd. - 531458 - Board Meeting Outcome for Approval Of Unaudited Financial Results …

BSE India

The Board has approved the Un-Audited Financial Results (Standalone) for the 3rd quarter ended 31st December, 2023 (F.Y. 2023-24) along with the Limited Review Report of the Auditors. The said results have been reviewed by the audit Committee and approved by the Board of Directors of the Company are enclosed

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Result

Boston Bio Systems Ltd. - 531458 - Results-Delay in Financial Results

BSE India

APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR QUATER ENDED ON 30TH SEPTEMBER, 2023.

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Corp. Note

Boston Bio Systems Ltd. - 531458 - Board Meeting Outcome for Approval Of Unaudited Financial Results …

BSE India

The Board has approved the Un-Audited Financial Results (Standalone) for the 2nd quarter ended 30th September, 2023 (F.Y. 2023-24) along with the Limited Review Report of the Auditors. The said results have been reviewed by the audit Committee and approved by the Board of Directors of the Company. In this regards, please find enclosed: a. Un-Audited Financial Results (standalone) for the 2nd quarter and half year ended 30th September, 2023 along with the Limited Review Report (standalone) of the Auditors' thereon; and b. Statement of Assets and Liabilities along with Cash Flow Statement half year ended 30th September, 2023.

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Result

Boston Bio Systems Ltd. - 531458 - Results-Delay in Financial Results

BSE India

APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR 1ST QUATER ENDED ON 30TH JUNE, 2023.

pdf

Boston Bio Systems Ltd.

20 Jul 2024

8.59

1.30%

Corp. Note

Boston Bio Systems Ltd. - 531458 - Board Meeting Outcome for Outcome Of The Board Of …

BSE India

Approval of Unaudited Financial results for the 1st Quarter ended 30 June, 2023 The Board has approved the Un-Audited Financial Results (Standalone) for the 1st quarter ended 30'' June, 2023 (F.Y. 2023-24) along with the Limited Review Report of the Auditors. The said results have been reviewed by the audit Committee and approved by the Board of Directors of the Company, are enclosed.

pdf

Boston Bio Systems Ltd.

29 Jun 2024

8.59

1.30%

Company Update

Boston Bio Systems Ltd. - 531458 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Outcome of Board Meeting under Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements)

pdf

Is Boston Bio Systems Ltd. worth buying?

1 Vote:

Buy 100.0%